Brokerages Set Teleflex Incorporated (NYSE:TFX) Price Target at $148.00

Teleflex Incorporated (NYSE:TFX) has received an average recommendation of “Hold” from the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $148.00.

A number of research analysts have issued reports on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and upped their target price for the company from $140.00 to $160.00 in a research report on Monday, June 8th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research report on Saturday, June 27th. BMO Capital Markets assumed coverage on Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target on the stock. Finally, Raymond James Financial reiterated an “outperform” rating and set a $150.00 price target on shares of Teleflex in a research note on Friday, May 8th.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Assenagon Asset Management S.A. purchased a new stake in Teleflex in the 2nd quarter valued at $1,391,000. GAMMA Investing LLC grew its position in Teleflex by 60.7% in the second quarter. GAMMA Investing LLC now owns 839 shares of the medical technology company’s stock worth $106,000 after acquiring an additional 317 shares during the period. Versant Capital Management Inc grew its position in Teleflex by 573.4% in the second quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock worth $55,000 after acquiring an additional 367 shares during the period. Glenmede Trust Co. NA increased its stake in Teleflex by 42.1% during the first quarter. Glenmede Trust Co. NA now owns 6,867 shares of the medical technology company’s stock worth $821,000 after acquiring an additional 2,036 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in Teleflex by 6.4% during the first quarter. Bank of America Corp DE now owns 445,958 shares of the medical technology company’s stock worth $53,341,000 after acquiring an additional 27,004 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Up 0.5%

Shares of TFX opened at $131.86 on Thursday. The firm has a market capitalization of $5.84 billion, a P/E ratio of -5.78, a P/E/G ratio of 0.98 and a beta of 0.82. Teleflex has a 12-month low of $100.18 and a 12-month high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The firm has a fifty day moving average price of $130.85 and a 200-day moving average price of $120.88.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the prior year, the firm earned $1.44 earnings per share. Teleflex’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a dividend of $0.34 per share. The ex-dividend date was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.